SCHEMBL7549372

SCHEMBL7549372

CCCCc1ncc(C(C(=O)O)(C(=O)O)C(CC)(CC)c2ccccc2)n1Cc1ccccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7055318 0.81 — —
SCHEMBL8536231 0.80 — —
SCHEMBL7676927 0.78 — —
SCHEMBL9472975 0.76 — —
SCHEMBL7269753 0.76 — —
SCHEMBL7549368 0.76 — —
Hydrochloric Acid SCHEMBL9473508 0.75 — —
SCHEMBL8954232 0.75 — —
SCHEMBL7269745 0.75 — —
SCHEMBL7059057 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020132840-A1 Treating angina in a mammal by administering an angiotensin II receptor antagonist. SMITHKLINE BEECHAM P.1.C. 2002-09-19 — — US disclosed
Send feedback